Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.

ClinicalTrials.gov ID: NCT00645281

Public ClinicalTrials.gov record NCT00645281. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 5:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Symptom Specific Effectiveness of Tolterodine ER 4 mg in Patients With Symptoms of Overactive Bladder (OAB) in a Primary Care Setting. A Phase IV, Open-label, Single-arm, Non-randomized, Trial in Adult Patients With OAB.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of tolterodine in impacting the primary symptom or complaint of patients with OAB.

Study identification

NCT ID
NCT00645281
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Enrollment
896 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2004
Primary completion
Not listed
Completion
Dec 31, 2004
Last update posted
Jan 26, 2021

2004 – 2005

United States locations

U.S. sites
96
U.S. states
27
U.S. cities
86
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35211
Pfizer Investigational Site Birmingham Alabama 35213
Pfizer Investigational Site Birmingham Alabama 35234
Pfizer Investigational Site Huntsville Alabama 35801
Pfizer Investigational Site Montgomery Alabama 36117
Pfizer Investigational Site Phoenix Arizona 85051
Pfizer Investigational Site Sun Lakes Arizona 85248
Pfizer Investigational Site Bentonville Arkansas 72712
Pfizer Investigational Site Jonesboro Arkansas 72401
Pfizer Investigational Site Little Rock Arkansas 72204
Pfizer Investigational Site Buena Park California 90620
Pfizer Investigational Site Foothill Ranch California 92610
Pfizer Investigational Site Fresno California 93710
Pfizer Investigational Site West Covina California 91790
Pfizer Investigational Site Colorado Springs Colorado 80904
Pfizer Investigational Site Lakewood Colorado 80228
Pfizer Investigational Site Chipley Florida 32428
Pfizer Investigational Site Davie Florida 33328
Pfizer Investigational Site Hallandale Florida 33009
Pfizer Investigational Site Miami Florida 33145
Pfizer Investigational Site Miami Beach Florida 33140
Pfizer Investigational Site Murdock Florida 33948
Pfizer Investigational Site Ocala Florida 34471
Pfizer Investigational Site Pembroke Pines Florida 33024
Pfizer Investigational Site Saint Cloud Florida 34769
Pfizer Investigational Site Tampa Florida 33607
Pfizer Investigational Site Atlanta Georgia 30308
Pfizer Investigational Site Barnesville Georgia 30204
Pfizer Investigational Site Blue Ridge Georgia 30513
Pfizer Investigational Site Decatur Georgia 30034
Pfizer Investigational Site Chicago Illinois 60610
Pfizer Investigational Site Naperville Illinois 60564
Pfizer Investigational Site Orland Park Illinois 60462
Pfizer Investigational Site Newton Kansas 67114
Pfizer Investigational Site Shawnee Mission Kansas 66203
Pfizer Investigational Site Wichita Kansas 67205
Pfizer Investigational Site Wichita Kansas 67207
Pfizer Investigational Site Marrero Louisiana 70072
Pfizer Investigational Site Laurel Maryland 20707
Pfizer Investigational Site Oxon Hill Maryland 20745
Pfizer Investigational Site Jackson Michigan
Pfizer Investigational Site Portage Michigan 49002
Pfizer Investigational Site St Louis Missouri 63117
Pfizer Investigational Site Las Vegas Nevada 89128
Pfizer Investigational Site Las Vegas Nevada 89146
Pfizer Investigational Site Blackwood New Jersey 08012
Pfizer Investigational Site Mount Laurel New Jersey 08054
Pfizer Investigational Site Binghamton New York 13901
Pfizer Investigational Site Endicott New York 13760
Pfizer Investigational Site Endwell New York 13760
Pfizer Investigational Site Kingston New York 12401
Pfizer Investigational Site Beaufort North Carolina 28516
Pfizer Investigational Site Charlotte North Carolina 28207
Pfizer Investigational Site Charlotte North Carolina 28262
Pfizer Investigational Site Durham North Carolina 27703
Pfizer Investigational Site Morehead City North Carolina 28557
Pfizer Investigational Site Winston-Salem North Carolina 27103
Pfizer Investigational Site Columbus Ohio 43213
Pfizer Investigational Site Kettering Ohio 45429
Pfizer Investigational Site Central Point Oregon 97502
Pfizer Investigational Site Medford Oregon 97504
Pfizer Investigational Site Bala-Cynwyd Pennsylvania 19004
Pfizer Investigational Site Bensalem Pennsylvania 19020
Pfizer Investigational Site Connellsville Pennsylvania 15425
Pfizer Investigational Site Philadelphia Pennsylvania 19103
Pfizer Investigational Site Philadelphia Pennsylvania 19147
Pfizer Investigational Site Philadelphia Pennsylvania 19148
Pfizer Investigational Site Sellersville Pennsylvania 18960
Pfizer Investigational Site Stoneboro Pennsylvania 16153
Pfizer Investigational Site Warwick Rhode Island 02886
Pfizer Investigational Site Greer South Carolina 29651
Pfizer Investigational Site Simpsonville South Carolina 29681
Pfizer Investigational Site Cordova Tennessee 38018
Pfizer Investigational Site Huntingdon Tennessee 38344
Pfizer Investigational Site Lexington Tennessee 38351
Pfizer Investigational Site Savannah Tennessee 38372
Pfizer Investigational Site Selmer Tennessee 38375
Pfizer Investigational Site Waynesboro Tennessee 38485
Pfizer Investigational Site Austin Texas 78705
Pfizer Investigational Site Bryan Texas 77802
Pfizer Investigational Site Colleyville Texas 76034
Pfizer Investigational Site Friendswood Texas 77546
Pfizer Investigational Site Houston Texas 77030
Pfizer Investigational Site Plano Texas 75093-5841
Pfizer Investigational Site Plano Texas 75093
Pfizer Investigational Site San Antonio Texas 78217
Pfizer Investigational Site Salt Lake City Utah 84109
Pfizer Investigational Site Salt Lake City Utah 84121
Pfizer Investigational Site West Jordan Utah 84084
Pfizer Investigational Site West Valley City Utah 84120
Pfizer Investigational Site Spokane Washington 99207
Pfizer Investigational Site Spokane Washington 99208
Pfizer Investigational Site Milwaukee Wisconsin 53221
Pfizer Investigational Site New Berlin Wisconsin 53151
Pfizer Investigational Site Oregon Wisconsin 53575
Pfizer Investigational Site Wauwatosa Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00645281, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 26, 2021 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00645281 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →